Automated Addressable Microfluidic Technology for Minimally Disruptive Manipulation of Cells and Fluids within Living Cultures

Technology Overview: This technology introduces an automated, addressable microfluidic system that enables precise manipulation of fluids and cells within living cultures. Individual regions of a culture can be selectively addressed without disrupting surrounding tissue, enabling localized stimulation, sampling, or treatment. The platform supports long‑term culture maintenance and real‑time control, making it highly valuable for advanced biological studies.

Industry Pain Point: Traditional cell culture methods lack spatial precision and often disrupt biological systems during intervention.

NJIT Solution: This technology enables minimally disruptive, targeted manipulation within live cultures.

Key Features & Advantages

• Addressable, region‑specific fluid control
• Automated and programmable operation
• Compatible with long‑term live cultures
• Enables complex biological experimentation

Development Stage: TRL 4–5 – Laboratory‑scale demonstrations completed.

Target Markets

• Advanced cell culture systems
• Organ‑on‑chip platforms
• Biomedical research tools

Market Opportunity

• Global organ‑on‑chip market (2026): ~$1.6B
• CAGR: ~18–20%
• Projected market size (2035): ~$7–8B